BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28520532)

  • 1. Effectiveness of SmartGuard Technology in the Prevention of Nocturnal Hypoglycemia After Prolonged Physical Activity.
    Petruzelkova L; Pickova K; Sumnik Z; Soupal J; Obermannova B
    Diabetes Technol Ther; 2017 May; 19(5):299-304. PubMed ID: 28520532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal predictive low glucose management settings during physical exercise in adolescents with type 1 diabetes.
    Cherubini V; Gesuita R; Skrami E; Rabbone I; Bonfanti R; Arnaldi C; D'Annunzio G; Frongia A; Lombardo F; Piccinno E; Schiaffini R; Toni S; Tumini S; Tinti D; Cipriano P; Minuto N; Lenzi L; Ferrito L; Ventrici C; Ortolani F; Cohen O; Scaramuzza A
    Pediatr Diabetes; 2019 Feb; 20(1):107-112. PubMed ID: 30378759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial.
    Battelino T; Nimri R; Dovc K; Phillip M; Bratina N
    Diabetes Care; 2017 Jun; 40(6):764-770. PubMed ID: 28351897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.
    Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
    Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes.
    Abraham MB; Nicholas JA; Smith GJ; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
    Diabetes Care; 2018 Feb; 41(2):303-310. PubMed ID: 29191844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
    Danne T; Tsioli C; Kordonouri O; Blaesig S; Remus K; Roy A; Keenan B; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2014 Jun; 16(6):338-47. PubMed ID: 24447074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary intake and risk of non-severe hypoglycemia in adolescents with type 1 diabetes.
    Zhong VW; Crandell JL; Shay CM; Gordon-Larsen P; Cole SR; Juhaeri J; Kahkoska AR; Maahs DM; Seid M; Forlenza GP; Mayer-Davis EJ
    J Diabetes Complications; 2017 Aug; 31(8):1340-1347. PubMed ID: 28476567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes.
    Abraham MB; Davey R; O'Grady MJ; Ly TT; Paramalingam N; Fournier PA; Roy A; Grosman B; Kurtz N; Fairchild JM; King BR; Ambler GR; Cameron F; Jones TW; Davis EA
    Diabetes Technol Ther; 2016 Sep; 18(9):543-50. PubMed ID: 27505305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia.
    Buckingham BA; Cameron F; Calhoun P; Maahs DM; Wilson DM; Chase HP; Bequette BW; Lum J; Sibayan J; Beck RW; Kollman C
    Diabetes Technol Ther; 2013 Aug; 15(8):622-7. PubMed ID: 23883408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study.
    Riddell MC; Milliken J
    Diabetes Technol Ther; 2011 Aug; 13(8):819-25. PubMed ID: 21599515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of Predictive Low-Glucose Management System in Hybrid of Full Closed Loop System.
    Choudhary P
    Diabetes Technol Ther; 2016 Jul; 18(7):408-9. PubMed ID: 27379979
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics of Automated Insulin Suspension and Glucose Responses with the Predictive Low-Glucose Management System.
    Abraham MB; Smith GJ; Nicholas JA; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
    Diabetes Technol Ther; 2019 Jan; 21(1):28-34. PubMed ID: 30585769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes.
    De Valk HW; Lablanche S; Bosi E; Choudhary P; Silva JD; Castaneda J; Vorrink L; De Portu S; Cohen O
    Diabetes Technol Ther; 2018 Nov; 20(11):758-766. PubMed ID: 30325656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis.
    Alotaibi A; Al Khalifah R; McAssey K
    Pediatr Diabetes; 2020 Nov; 21(7):1256-1267. PubMed ID: 32738022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.
    Gómez AM; Henao DC; Imitola A; Muñoz OM; Sepúlveda MAR; Kattah L; Guerrero JS; Morros E; Llano JP; Jaramillo MG; León-Vargas F
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Oct; 65(8):451-457. PubMed ID: 29914817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes.
    Collyns OJ; Meier RA; Betts ZL; Chan DSH; Frampton C; Frewen CM; Hewapathirana NM; Jones SD; Roy A; Grosman B; Kurtz N; Shin J; Vigersky RA; Wheeler BJ; de Bock MI
    Diabetes Care; 2021 Apr; 44(4):969-975. PubMed ID: 33579715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.